HHS updates COVID-19 laboratory reporting requirements

Mar 11, 2022 - 12:20 PM
HHS Logo web sized 900x400

Effective April 4, the Department of Health and Human Services will no longer require COVID-19 testing facilities to report negative results for tests authorized for use under a Clinical Laboratory Improvement Amendment certificate of waiver, the Centers for Disease Control and Prevention reports. 

“This includes rapid and antigen testing performed for screening testing at schools, correctional facilities, employee testing programs, long-term care facilities, and rapid testing performed in pharmacies, medical provider offices, and drive-through and pop-up testing sites,” CDC said. 

Among other changes, HHS will no longer require testing facilities to report positive or negative antibody test results, but will still require laboratories certified under CLIA to report positive and negative results for nucleic acid amplification tests, CDC said. 

For details, see the updated HHS guidance. 
 

Related News Articles

Headline
CDC encourages older adults to get additional COVID-19 vaccine dose 
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
FDA: Paxlovid no longer labeled for emergency use after March 8
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
FDA advisor declares ineffectiveness of widely used over-the-counter decongestant active ingredient
The Food and Drug Administration’s independent Nonprescription Drugs Advisory Committee Sept. 12 by unanimous vote declared oral phenylephrine…
Headline
Senate committee advances bill to reauthorize preparedness programs
The Senate Health, Education, Labor and Pensions Committee today 17-3 to pass as amended the Pandemic and All-Hazards Preparedness and Response Act (S. 2333),…
Headline
FDA advisory panel recommends monovalent XBB COVID-19 vaccine for fall 
The Food and Drug Administration’s vaccine advisory committee June 15 voted unanimously to recommend updating the current COVID-19 vaccine composition for…
Headline
CDC data confirm third COVID-19 vaccine dose safe in young children
The first data on the safety of a third mRNA COVID-19 vaccine dose among young children show that a third dose is safe for children ages 6 months to 5 years…